Peppu Wiki← peppu.studio

Wolverine Blend

Category: Stacks · Last updated

Wolverine Blend is a community-named multi-peptide research panel that co-formulates the three best-studied tissue-repair compounds in the peptide-research space: BPC-157, TB-500, and GHK-Cu. The name is a reference to the fictional Marvel character known for accelerated tissue healing.

Peppudex card: see the mechanism + evidence-grade summary at [Peppudex / Wolverine Blend](https://peppudex.com/peptides/wolverine-blend).

Overview

The Wolverine stack is a research-protocol convention more than a single chemistry. Vendor blends typically lyophilize three peptides in a single vial at fixed ratios so that one reconstitution covers a multi-compound research run. The exact mass ratios vary by vendor; Peppu Labs' KLOW is a four-component variant that adds Kisspeptin.

Mechanism

The three components address parallel arms of the tissue-remodeling cascade:

  • BPC-157 · upregulates VEGF-driven Angiogenesis and modulates the nitric-oxide pathway in injured tissue.
  • TB-500 · synthetic Thymosin_beta-4 fragment with documented activity on Actin sequestering, cell migration, and capillary formation.
  • GHK-Cu · copper tripeptide with broad transcriptional effects on extracellular-matrix genes (collagen I/III, elastin, glycosaminoglycans) and antioxidant pathways.

The pharmacological argument for blending is that recovery is multi-step, and supplying parallel signals (angiogenesis + migration + matrix remodeling) is more efficient than addressing one phase at a time.

Evidence

There are no head-to-head clinical trials of the three-peptide blend. Each component carries its own animal-model evidence base; combination effects are inferred from mechanism rather than measured directly. The blend is therefore a research-protocol convention rather than a validated therapy.

Dosing literature

Vendor-supplied research blends typically dose at 250-500 µg of BPC-157, 2-5 mg of TB-500, and 1-2 mg of GHK-Cu per administration in published protocols. The wiki does not recommend any human dose. See the individual compound pages and Reconstitution for vial-prep math.

Storage

Lyophilized blend is stable at –20 °C for at least 24 months. Once reconstituted in bacteriostatic water, store at 2-8 °C and use within 28 days. Protect from light because GHK-Cu is sensitive to copper oxidation.

Regulatory status

  • United States. Component peptides are research-use only. BPC-157 is on the FDA Category 2 of the 503A bulks list (compounding restricted).
  • WADA. BPC-157, TB-500, and GHK-Cu are prohibited under S0 (non-approved substances) on the [WADA Prohibited List](https://www.wada-ama.org/en/prohibited-list).

See also

References

  • Sikiric P, et al. "Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease." Curr Pharm Des. 2011;17(16):1612-32. PMID 21548867.
  • Goldstein AL, et al. "Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues." Trends Mol Med. 2005;11(9):421-9. PMID 16099219.
  • Pickart L, et al. "GHK-Cu may prevent oxidative stress in skin." Oxid Med Cell Longev. 2012;2012:530-46. PMID 22666519.
Research framing only. Peppu Wiki documents the published research literature surrounding peptide compounds. Articles describe in-vitro and animal-model evidence, regulatory status, and community-reported protocols. Nothing on this site is medical advice, a recommendation for human use, or a substitute for consultation with a qualified clinician. All compounds discussed are research-use only. Citations should be verified at the source before relying on any quantitative claim.
View edit history of this page